# US 2023/0265502 A1 · Cyclooctatetraene containing dyes and compositions

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0265502 A1
- Document ID: US20230265502A1
- Status: Published application
- Kind: A1
- Application number: 18/168,856
- Filed: 2023-02-14
- Published: 2023-08-24
- Earliest claimed: 2019-11-27
- Assignees: Illumina Cambridge Limited
- Applicants: Illumina Cambridge Limited
- Inventors: Xiaolin WU; Xiaohai LIU; Nikolai Nikolaevich ROMANOV; Antoine FRANCAIS; Patrick MCCAULEY; Michael CALLINGHAM; Carole ANASTASI
- Web page: https://patentgrep.com/patent/US20230265502A1

## CPC

- C12Q 1/6869: Methods for sequencing
- C07H 19/06: Pyrimidine radicals
- C07H 19/16: Purine radicals
- C07H 21/04: with deoxyribosyl as saccharide radical
- C09B 57/02: Coumarine dyes
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C07H: SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS (derivatives of aldonic or saccharic acids C07C, C07D; aldonic acids, saccharic acids C07C59/105, C07C59/285; cyanohydrins C07C255/16; glycals C07D; compounds of unknown constitution C07G; polysaccharides, derivatives thereof C08B; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; sugar industry C13)
- C09B: ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES {, e.g. PIGMENTS}; MORDANTS; LAKES (fermentation or enzyme using processes to synthesise a desired chemical compound C12P)

## Abstract

Embodiments of the present disclosure relate to cyclooctatetraene containing dyes and their uses as fluorescent labels. Also provided are composition containing cyclooctatetraene. The dyes and compositions may be used in various biological applications, such as nucleic acid sequencing.

## Claims

### Claim 1

(canceled)

### Claim 2

A nucleotide labeled with a fluorescent compound, wherein fluorescent compound comprises a photo-protecting moiety having the structure of formula (I):
each of R1 and R2 is independently selected from the group consisting of H, —NH2, substituted amino, carboxyl, —C(O)OR5, —C(O)NR6R7, unsubstituted C1-6 alkyl and substituted C1-6 alkyl;
X is —C(═O)—NR4—;
Y is selected from the group consisting of —NR3—, —C(═O)—, —C(═O)—O—, —C(═O)—NR4—, —S(O)2—, —NR3—C(═O)—NR4, and —NR3—C(═S)—NR4—;
Z is absent, unsubstituted C2-6 alkenylene, or unsubstituted C2-6 alkynylene;
each of R3, R4, R6 and R7 is independently H, unsubstituted C1-6 alkyl, or substituted C1-6 alkyl;
R5 is unsubstituted or substituted C1-6 alkyl;
m is an integral number between 1 and 10;
provided that the fluorescent compound is not a cyanine dye, and wherein the fluorescent compound is excitable by a light source having a wavelength between about 350 nm to about 500 nm.

### Claim 3 (depends on 2)

The nucleotide of claim 2, wherein Z is absent.

### Claim 4 (depends on 2)

The nucleotide of claim 2, wherein R4 is H.

### Claim 5 (depends on 2)

The nucleotide of claim 2, wherein R4 is C1-6 alkyl substituted with —NH2, —SO3H, —SO3−, carboxyl, —C(O)OR5, or —C(O)NR6R7.

### Claim 6 (depends on 2)

The nucleotide of claim 2, wherein Y is —C(═O)—O—, —NR3— or —S(O)2—.

### Claim 7 (depends on 6)

The nucleotide of claim 6, wherein Y is —NR3— and R3 is H or C1-6 alkyl substituted with —NH2, carboxyl, —SO3H, —SO3−, —C(O)OR5, or —C(O)NR6R7.

### Claim 8 (depends on 7)

The nucleotide of claim 7, wherein the photo-protecting moiety has the structure of formula (Ia) or (Id):

### Claim 9 (depends on 2)

The nucleotide of claim 2, wherein at least one of R1 and R2 is hydrogen.

### Claim 10 (depends on 9)

The nucleotide of claim 9, wherein m is 2, 3, 4, 5 or 6, and each one of R1 and R2 is hydrogen.

### Claim 11 (depends on 9)

The nucleotide of claim 9, wherein m is 2, 3, 4, 5 or 6, wherein each one of R1 and R2 is hydrogen in
and wherein R1 is H; and R2 is —NH2, carboxyl, —C(O)OR5, or —C(O)NR6R7 in the remaining

### Claim 12 (depends on 11)

The nucleotide of claim 11, wherein R6 is H and R7 is C1-6 alkyl substituted with carboxyl, —NH2, —SO3H, or —SO3−.

### Claim 13 (depends on 11)

The nucleotide of claim 11, wherein both R6 and R7 are independently C1-6 alkyl substituted with carboxyl, —NH2, —SO3H, or —SO3−.

### Claim 14 (depends on 2)

The nucleotide of claim 2, wherein the photo-protecting moiety has the structure:

### Claim 15 (depends on 2)

The nucleotide of claim 2, wherein the fluorescent compound is excitable by a light source having a wavelength between about 420 nm and about 480 nm, or between about 450 nm and about 460 nm.

### Claim 16 (depends on 2)

A kit comprising two or more different types of nucleotides, wherein at least one type of nucleotide is a labeled nucleotide according to claim 2.

### Claim 17 (depends on 2, 16)

The kit according to claim 16, comprising four different types of nucleotides, wherein a first type of nucleotide is a labeled nucleotide according to claim 2, and the second, third, and fourth types of nucleotides are each labeled with a different compound, wherein each compound has a distinct absorbance maximum and each of the compounds is spectrally distinguishable from the other three compounds.

### Claim 18 (depends on 2, 16)

The kit according to claim 16, comprising four different types of nucleotides, wherein a first type of nucleotide is a labeled nucleotide according to claim 2, a second type of nucleotide is labeled with a spectrally distinct second fluorescent compound, a third type of nucleotide is labeled with both the fluorescent compound and the spectrally distinct second fluorescent compound, and a fourth type of nucleotide is unlabeled (dark).

### Claim 19 (depends on 18)

The kit of claim 18, wherein the four different types of nucleotides are excitable using two lasers with two different wavelengths.

### Claim 20 (depends on 19)

The kit of claim 19, wherein at least one laser has a wavelength from about 420 nm to about 480 nm, or from about 450 nm to about 460 nm.

### Claim 21 (depends on 14)

A kit comprising two or more different types of nucleotides, wherein at least one type of nucleotide is a labeled nucleotide according to claim 14.

### Claim 22 (depends on 2)

A method of reducing or preventing light-induced degradation of nucleic acids during nucleic acid sequencing reaction, comprising:
(a) contacting a solid support with an incorporation mixture comprising DNA polymerase and one or more of four different types of nucleotides, wherein the solid support comprises a plurality of immobilized target polynucleotides and sequencing primers that are complementary and hybridized to at least a portion of the target polynucleotides, wherein one or more of four different types of nucleotides carriers a fluorescent label, one type of nucleotides is the nucleotide of claim 2, and each type of nucleotides comprises a 3′ blocking group;
(b) incorporating one type of nucleotides into sequencing primers to produce extended copy polynucleotide strands;
(c) performing one or more fluorescent measurements to determine the identity of the incorporated nucleotides in a first buffer composition;
(d) chemically removing the 3′ blocking group of the incorporated nucleotides; and
(e) washing the extended copy polynucleotide strands with a wash solution.

### Claim 23 (depends on 22)

The method of claim 22, wherein step (d) also removes the fluorescent label of the incorporated nucleotides.

### Claim 24 (depends on 22)

The method of claim 22, wherein steps (a) to (e) are repeated at least 50 times.

### Claim 25 (depends on 22)

The method of claim 22, wherein step (c) comprises irradiating the extended copy polynucleotide strands in the first buffer composition with a light source having a wavelength from about 400 nm to about 500 nm.

### Claim 26 (depends on 22)

The method of claim 22, wherein step (d) comprises contacting the extended copy polynucleotide strands with a phosphine.

### Claim 27 (depends on 26)

The method of claim 26, wherein the phosphine is tris(hydroxymethyl)phosphine, tris(hydroxyethyl)phosphine, or tris(hydroxypropyl)phosphine.

### Claim 28 (depends on 22)

The method of claim 22, wherein the first buffer solution comprises ascorbic acid or a salt thereof.

### Claim 29 (depends on 14)

A method of reducing or preventing light-induced degradation of nucleic acids during nucleic acid sequencing reaction, comprising:
(a) contacting a solid support with an incorporation mixture comprising DNA polymerase and one or more of four different types of nucleotides, wherein the solid support comprises a plurality of immobilized target polynucleotides and sequencing primers that are complementary and hybridized to at least a portion of the target polynucleotides, wherein one or more of four different types of nucleotides each carriers a fluorescent label, one type of nucleotides is the nucleotide of claim 14, and each type of nucleotides comprises a 3′ blocking group;
(b) incorporating one type of nucleotides into sequencing primers to produce extended copy polynucleotide strands;
(c) performing one or more fluorescent measurements to determine the identity of the incorporated nucleotides in a first buffer composition;
(d) chemically removing the 3′ blocking group of the incorporated nucleotides; and
(e) washing the extended copy polynucleotide strands with a wash solution.
